Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
Authors
Lee S, Monz BU, Clemens A, Brueckmann M, Lip GYH
Journal
BMJ Open
Publication Date
2012
Impact Factor
1.583
Abstract
Additional IDs
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens